QUESTCOR PHARMA
PharmaQUESTCOR PHARMA is a pharmaceutical company focused on Immunology, Neurology.
QUESTCOR PHARMA's Key Drugs
QUESTCOR PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
QUESTCOR PHARMA's Recent FDA Approvals
New NDA/BLA approvals for QUESTCOR PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
QUESTCOR PHARMA's Therapeutic Areas
QUESTCOR PHARMA's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Neurology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
QUESTCOR PHARMA's Top Competitors
QUESTCOR PHARMA's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
QUESTCOR PHARMA Pipeline Snapshot
Active clinical trials for QUESTCOR PHARMA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2010-10-15
- Latest
- 2010-10-15
- Applications
- 1